Yoshida H, Okumura K, Kamiya A, Hori R
Chem Pharm Bull (Tokyo). 1989 Feb;37(2):450-3. doi: 10.1248/cpb.37.450.
The mechanism of the accumulation of basic drugs was investigated by isolated rat lung perfusion. Treatment with various metabolic inhibitors or non-basic drugs did not affect the accumulation of a basic drug in the lung, but a second basic drug inhibited the accumulation of the first basic drug depending on its lipid solubility. The basic drug already accumulated was rapidly displaced by the second drug except for poorly lipid-soluble basic drugs and non-basic drugs. The ability of a second basic drug to displace the first basic drug was well correlated with its ability to inhibit accumulation. From the Scatchard plot, at least two independent sets of binding sites for basic drugs were found to be present in the isolated perfused lung. The maximum binding capacity for each basic drug was similar in both sites. These results indicate that specific common binding sites for basic drugs, which do not contribute to the active transport system, exist in the lung tissues and the affinity to the sites depends on the lipid solubility of the basic drugs.
通过离体大鼠肺灌注研究了碱性药物的蓄积机制。用各种代谢抑制剂或非碱性药物处理并不影响碱性药物在肺中的蓄积,但第二种碱性药物会根据其脂溶性抑制第一种碱性药物的蓄积。除了脂溶性差的碱性药物和非碱性药物外,已蓄积的碱性药物会被第二种药物迅速取代。第二种碱性药物取代第一种碱性药物的能力与其抑制蓄积的能力密切相关。从Scatchard图中发现,在离体灌注肺中至少存在两组独立的碱性药物结合位点。每个碱性药物在两个位点的最大结合容量相似。这些结果表明,肺组织中存在对碱性药物具有特异性的共同结合位点,这些位点对主动转运系统无贡献,且对这些位点的亲和力取决于碱性药物的脂溶性。